Skip to content

Randomized Trial Of Tinnitus Retraining Therapy

Randomized Trial Of Tinnitus Retraining Therapy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00578058
Enrollment
180
Registered
2007-12-20
Start date
2004-01-31
Completion date
2009-11-30
Last updated
2011-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Brief summary

Millions of Americans suffer from tinnitus. However, there is no widely accepted treatment that has been shown to be effective in controlled investigations. The purpose of this study is to evaluate the effectiveness of Tinnitus Retraining Therapy (TRT). This study will investigate the contributions of counseling, the use of hearing aids and sound generators, and the importance of setting masking noise to a particular level. All groups will receive the same Counseling. In pilot studies we have developed a picture-based counseling protocol. The results of this study will determine if TRT is more effective than masking or counseling alone.

Interventions

OTHERCounseling and Sound Therapy

Tinnitus counseling and sound therapy

Sponsors

National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH
University of Iowa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Have experienced tinnitus for at least 4 months. * Have the ability to participate in research.

Exclusion criteria

* Have a treatable otological disorder. * Are involved in litigation. * Have or are suspected of having a serious psychiatric problem.

Design outcomes

Primary

MeasureTime frame
Iowa Tinnitus Handicap Questionnaire18 months

Secondary

MeasureTime frame
Tinnitus measures18 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026